HPV疫苗今年内纳入国家免疫规划，在校适龄女生有望免费

Core Viewpoint - The inclusion of the HPV vaccine in the national immunization program marks a significant expansion, prioritizing coverage for eligible girls and transitioning the program towards a "lifecycle vaccination" approach [1][5]. Group 1: HPV Vaccine Inclusion and Impact - The HPV vaccine will be a bivalent type, primarily targeting girls of appropriate age, and is expected to be added to the national immunization program within the year [1]. - Cervical cancer is a leading cause of cancer-related deaths among women globally, with China accounting for 23% of cases and 16% of deaths worldwide [2]. - The World Health Organization recommends that member countries include HPV vaccination in their national immunization programs, aiming for 90% of girls to be vaccinated by age 15 [2]. Group 2: Current Vaccination Efforts and Accessibility - As of August, 18 provinces and several cities in China have included HPV vaccination in government initiatives, providing free vaccinations to approximately 60% of eligible girls [3]. - Public awareness and willingness to vaccinate have increased, with 82% of surveyed individuals expressing a desire to vaccinate their daughters against HPV [3]. - The national immunization information system has been fully established, enabling dynamic monitoring of HPV vaccination status [3]. Group 3: Vaccine Development and Cost Reduction - The production and research capabilities for HPV vaccines in China have significantly improved, with two bivalent vaccines approved and widely used [4]. - The price of the bivalent HPV vaccine has decreased dramatically due to provincial centralized procurement, with the lowest bid price now at 27.5 yuan per dose, less than one-tenth of the initial price [4]. Group 4: Future Directions and Strategies - The successful inclusion of the HPV vaccine is expected to enhance the integration of primary and secondary prevention strategies for cervical cancer [5]. - A comprehensive prevention strategy combining vaccination, screening, and early diagnosis is being developed [6]. - Future plans include expanding the types of vaccines in the national immunization program and optimizing existing vaccination protocols based on epidemiological trends and vaccine characteristics [6].